(Q35881722)

10 August 2017

Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers (English)

1 reference

10 August 2017

0 references

4

Robert Sebra

1 reference

10 August 2017

15

Eric Schadt

1 reference

10 August 2017

Elena Pereira

1

1 reference

10 August 2017

Olga Camacho-Vanegas

2

1 reference

10 August 2017

Sanya Anand

3

1 reference

10 August 2017

Sandra Catalina Camacho

5

1 reference

10 August 2017

Leopold Garnar-Wortzel

6

1 reference

10 August 2017

Navya Nair

7

1 reference

10 August 2017

Erin Moshier

8

1 reference

10 August 2017

Melissa Wooten

9

1 reference

10 August 2017

Andrew Uzilov

10

1 reference

10 August 2017

Rong Chen

11

1 reference

10 August 2017

Monica Prasad-Hayes

12

1 reference

10 August 2017

Konstantin Zakashansky

13

1 reference

10 August 2017

Ann Marie Beddoe

14

1 reference

10 August 2017

Peter Dottino

16

1 reference

10 August 2017

John A Martignetti

17

1 reference

10 August 2017

language of work or name

English

0 references

publication date

30 December 2015

1 reference

10 August 2017

1 reference

10 August 2017

10

1 reference

10 August 2017

12

1 reference

10 August 2017

e0145754

1 reference

Creative Commons Attribution 4.0 International

10 August 2017

start time

30 December 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Circulating tumor DNA outperforms circulating tumor cells for KRAS mutation detection in thoracic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Monitoring gastric cancer progression with circulating tumour DNA.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Which imaging technique should we use in the follow up of gynaecological cancer?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Personalized ovarian cancer disease surveillance and detection of candidate therapeutic drug target in circulating tumor DNA.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Detection of circulating tumor DNA in early- and late-stage human malignancies

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Analysis of circulating tumor DNA to monitor metastatic breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Effect of Screening on Ovarian Cancer Mortality

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

CA 125 and the detection of recurrent ovarian cancer: a reasonably accurate biomarker for a difficult disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Role of tumour markers in monitoring epithelial ovarian cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4696808

Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26717006

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26717006

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26717006

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0145754

1 reference

10 August 2017

0 references

1 reference

10 August 2017

1 reference